Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Neoplasms of the CNS

  Free Subscription


19.02.2024

2 Acta Neuropathol
1 AJNR Am J Neuroradiol
2 BMC Cancer
2 Br J Cancer
1 Cancer
2 Childs Nerv Syst
1 Clin Cancer Res
1 Int J Cancer
2 J Clin Oncol
10 J Neurooncol
2 J Neurosurg
1 J Nucl Med
2 Neuro Oncol
1 Neurology
3 Neuroradiology
9 Neurosurgery
1 Oncogene
1 Pediatr Hematol Oncol
2 Proc Natl Acad Sci U S A
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. RAHMANZADE R, Sahm F
    Reply: pineal parenchymal tumors of intermediate differentiation: in need of a stringent definition to avoid confusion.
    Acta Neuropathol. 2024;147:35.
    PubMed        

  2. VASILJEVIC A
    Pineal parenchymal tumors of intermediate differentiation: in need of a stringent definition to avoid confusion. Scientific commentary on 'Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate diffe
    Acta Neuropathol. 2024;147:34.
    PubMed        


    AJNR Am J Neuroradiol

  3. AGARWAL A, Bathla G, Soni N, Desai A, et al
    Newly Recognized Genetic Tumor Syndromes of the CNS in the 5th WHO Classification: Imaging Overview with Genetic Updates.
    AJNR Am J Neuroradiol. 2024;45:128-138.
    PubMed         Abstract available


    BMC Cancer

  4. BOCCACINO JM, Dos Santos Peixoto R, Fernandes CFL, Cangiano G, et al
    Integrated transcriptomics uncovers an enhanced association between the prion protein gene expression and vesicle dynamics signatures in glioblastomas.
    BMC Cancer. 2024;24:199.
    PubMed         Abstract available

  5. SHIM YB, Oh BC, Lee EK, Park MH, et al
    Comparison of partitioned survival modeling with state transition modeling approaches with or without consideration of brain metastasis: a case study of Osimertinib versus pemetrexed-platinum.
    BMC Cancer. 2024;24:189.
    PubMed         Abstract available


    Br J Cancer

  6. CHIANG JY, Wei ST, Chang HJ, Chen DC, et al
    ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling.
    Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-024-02581.
    PubMed         Abstract available

  7. PRETE AA, Angerilli V, Bergamo F, Vettore V, et al
    HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study.
    Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-023-02569.
    PubMed         Abstract available


    Cancer

  8. ZHOU Y, Guo T, Liang F, Wang Z, et al
    Cumulative incidence and risk factors of brain metastases in metastatic non-small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IMpower131, and IMpower150.
    Cancer. 2024 Feb 14. doi: 10.1002/cncr.35242.
    PubMed         Abstract available


    Childs Nerv Syst

  9. ZAHID N, Enam SA, Martensson T, Azam I, et al
    Predictors of neurocognition outcomes in children and young people with primary brain tumor presenting to tertiary care hospitals of Karachi, Pakistan: a prospective cohort study.
    Childs Nerv Syst. 2024 Feb 16. doi: 10.1007/s00381-024-06306.
    PubMed         Abstract available

  10. LI Y, Li Y, Liu J, Pang C, et al
    Concurrent spinal meningioma and giant invasive schwannoma without neurofibromatosis in children: A case report and literature review.
    Childs Nerv Syst. 2024 Feb 13. doi: 10.1007/s00381-024-06300.
    PubMed         Abstract available


    Clin Cancer Res

  11. FANGUSARO J, Avery RA, Fisher MJ, Packer RJ, et al
    Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.
    Clin Cancer Res. 2024 Feb 15. doi: 10.1158/1078-0432.CCR-23-3386.
    PubMed         Abstract available


    Int J Cancer

  12. WEIJERS DD, Hirsch S, Bakhuizen JJ, van Engelen N, et al
    Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations.
    Int J Cancer. 2024;154:1455-1463.
    PubMed         Abstract available


    J Clin Oncol

  13. ARRILLAGA-ROMANY I, Gardner SL, Odia Y, Aguilera D, et al
    ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
    J Clin Oncol. 2024 Feb 9:JCO2301134. doi: 10.1200/JCO.23.01134.
    PubMed         Abstract available

  14. WU J, Heidelberg RE, Gajjar A
    Adolescents and Young Adults With Cancer: CNS Tumors.
    J Clin Oncol. 2024;42:686-695.
    PubMed         Abstract available


    J Neurooncol

  15. WASILEWSKI D, Onken J, Horicke P, Bukatz J, et al
    Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection.
    J Neurooncol. 2024 Feb 15. doi: 10.1007/s11060-024-04590.
    PubMed         Abstract available

  16. DONO A, Torres J, Nunez L, Arevalo O, et al
    Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype.
    J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04575.
    PubMed         Abstract available

  17. KOAY JM, Michaelides L, Moniz-Garcia DP, Quinones-Hinojosa A, et al
    Repeated surgical resections for management of high-grade glioma and its impact on quality of life.
    J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04600.
    PubMed         Abstract available

  18. ANGELOVA P, Gicheva M
    Comment: Additional factors affecting cognitive function in low grade glioma patients.
    J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04598.
    PubMed        

  19. WATANABE G, Wong JM, Estes B, Khan MF, et al
    Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review.
    J Neurooncol. 2024 Feb 12. doi: 10.1007/s11060-024-04584.
    PubMed         Abstract available

  20. FAIRCHILD A, Salama JK, Godfrey D, Wiggins WF, et al
    Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery.
    J Neurooncol. 2024 Feb 10. doi: 10.1007/s11060-024-04594.
    PubMed         Abstract available

  21. MIRIAN C, Jensen LR, Juratli TA, Maier AD, et al
    The importance of considering competing risks in recurrence analysis of intracranial meningioma.
    J Neurooncol. 2024 Feb 10. doi: 10.1007/s11060-024-04572.
    PubMed         Abstract available

  22. SHIRAI Y, Ueno T, Kojima S, Ikeuchi H, et al
    The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
    J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04563.
    PubMed         Abstract available

  23. SHEEHAN JP, Mantziaris G, Bunevicius A
    Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma.
    J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04592.
    PubMed        

  24. ARNOLD LM, Hoshina Y, Lee H, Colman H, et al
    Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors.
    J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04588.
    PubMed         Abstract available


    J Neurosurg

  25. SAMANCI Y, Peker S
    Letter to the Editor. Anterior clinoid meningioma and radiosurgery.
    J Neurosurg. 2024 Feb 16:1-2. doi: 10.3171/2023.12.JNS232820.
    PubMed        

  26. SAWAYA R, Yamaguchi S, Ishi Y, Okamoto M, et al
    Increased CD44 expression in primary meningioma: its clinical significance and association with peritumoral brain edema.
    J Neurosurg. 2024 Feb 9:1-8. doi: 10.3171/2023.11.JNS231884.
    PubMed         Abstract available


    J Nucl Med

  27. LOHMANN P, Gutsche R, Werner JM, Shah NJ, et al
    Example of Artificial Intelligence-Based Decision Support for Amino Acid PET: Early Prediction of Suspected Brain Tumor Foci for Patient Management.
    J Nucl Med. 2024 Feb 15:jnumed.123.267112. doi: 10.2967/jnumed.123.267112.
    PubMed        


    Neuro Oncol

  28. MOREIRA DC, Bouffet E, Qaddoumi I
    The greatest challenge for pediatric low-grade glioma.
    Neuro Oncol. 2024 Feb 10:noae004. doi: 10.1093.
    PubMed        

  29. SILVESTRI VL, Tran AD, Chung M, Chung N, et al
    Distinct uptake and elimination profiles for trastuzumab, human IgG and biocytin-TMR in experimental HER2+ brain metastases of breast cancer.
    Neuro Oncol. 2024 Feb 13:noae025. doi: 10.1093.
    PubMed         Abstract available


    Neurology

  30. LE RHUN E, Devos P, Seystahl K, Jongen JLM, et al
    Prognostic Role of Ventricular Size and Its Dynamics in Patients With Leptomeningeal Metastasis From Solid Tumors.
    Neurology. 2024;102:e207959.
    PubMed         Abstract available


    Neuroradiology

  31. KIKUCHI K, Togao O, Yamashita K, Momosaka D, et al
    Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and
    Neuroradiology. 2024 Jan 15. doi: 10.1007/s00234-024-03288.
    PubMed         Abstract available

  32. FANG Y, Wang H, Cao D, Cai S, et al
    Multi-center application of a convolutional neural network for preoperative detection of cavernous sinus invasion in pituitary adenomas.
    Neuroradiology. 2024;66:353-360.
    PubMed         Abstract available

  33. MALIK P, Soliman R, Chen YA, Munoz DG, et al
    Patterns of T2-FLAIR discordance across a cohort of adult-type diffuse gliomas and deviations from the classic T2-FLAIR mismatch sign.
    Neuroradiology. 2024 Feb 13. doi: 10.1007/s00234-024-03297.
    PubMed         Abstract available


    Neurosurgery

  34. KOESTER SW, Lu VM, Basil GW
    Letter: Predictors of Progression-Free Survival in Patients With Spinal Intramedullary Ependymoma: A Multicenter Retrospective Study by the Neurospinal Society of Japan.
    Neurosurgery. 2023 Sep 12. doi: 10.1227/neu.0000000000002682.
    PubMed        

  35. NAITO K
    In Reply: Predictors of Progression-Free Survival in Patients With Spinal Intramedullary Ependymoma: A Multicenter Retrospective Study by the Neurospinal Society of Japan.
    Neurosurgery. 2023 Sep 11. doi: 10.1227/neu.0000000000002683.
    PubMed        

  36. FINDLAY MC, Drexler R, Karsy M
    In Reply: A Multicenter, Propensity Score-Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas.
    Neurosurgery. 2023 Sep 5. doi: 10.1227/neu.0000000000002657.
    PubMed        

  37. D'ONOFRIO GF, Chiloiro S, Menna G, Mattogno PP, et al
    Letter: A Multicenter, Propensity Score-Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas.
    Neurosurgery. 2023 Aug 28. doi: 10.1227/neu.0000000000002656.
    PubMed        

  38. DAYAWANSA S, Abbas SO, Mantziaris G, Dumot C, et al
    Volumetric Assessment of Nonfunctional Pituitary Adenoma Treated With Stereotactic Radiosurgery: An Assessment of Long-Term Response.
    Neurosurgery. 2023 Jul 12. doi: 10.1227/neu.0000000000002594.
    PubMed         Abstract available

  39. NAITO K, Umebayashi D, Kurokawa R, Endo T, et al
    Predictors of Progression-Free Survival in Patients With Spinal Intramedullary Ependymoma: A Multicenter Retrospective Study by the Neurospinal Society of Japan.
    Neurosurgery. 2023 May 31. doi: 10.1227/neu.0000000000002538.
    PubMed         Abstract available

  40. LEE JH, Holste KG, Selzer BJ, Garton HJL, et al
    Sports Participation and Sports-Related Neurologic Injuries in Pediatric Patients With Arachnoid Cysts.
    Neurosurgery. 2023 May 18. doi: 10.1227/neu.0000000000002537.
    PubMed         Abstract available

  41. YOO KH, Park DJ, Marianayagam NJ, Gu X, et al
    Stereotactic Radiosurgery for Cranial and Spinal Hemangioblastomas: A Single-Institution Retrospective Series.
    Neurosurgery. 2023 Oct 17. doi: 10.1227/neu.0000000000002728.
    PubMed         Abstract available

  42. PICHARDO-ROJAS PS, Dono A, Ballester LY, Esquenazi Y, et al
    Commentary: Novel Postoperative Serum Biomarkers in Atypical Meningiomas: A Multicenter Study.
    Neurosurgery. 2023;93:e129-e130.
    PubMed        


    Oncogene

  43. SHENG H, Li H, Zeng H, Zhang B, et al
    Heterogeneity and tumoral origin of medulloblastoma in the single-cell era.
    Oncogene. 2024 Feb 14. doi: 10.1038/s41388-024-02967.
    PubMed         Abstract available


    Pediatr Hematol Oncol

  44. VILLANUEVA G, Lowe J, Tentoni N, Taluja A, et al
    Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity.
    Pediatr Hematol Oncol. 2024;41:135-149.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  45. KUDRUK S, Forsyth CM, Dion MZ, Hedlund Orbeck JK, et al
    Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.
    Proc Natl Acad Sci U S A. 2024;121:e2306973121.
    PubMed         Abstract available

  46. NOCH EK, Palma L, Yim I, Bullen N, et al
    Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production.
    Proc Natl Acad Sci U S A. 2024;121:e2317343121.
    PubMed         Abstract available


    Radiology

  47. WAGNER MW, Jabehdar Maralani P, Bennett J, Nobre L, et al
    Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor Types.
    Radiology. 2024;310:e230777.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.